Extended Data Fig. 6: Change in T cell biomarker gene expression in the tumor upon PTCV treatment.

T cell activation biomarkers are evaluated in pair-matched tumor biopsy samples from (a) responder (CR/PR; n = 9) and (b) non-responder (SD/PD; n = 15) patients treated with PTCV. Significance was tested by a two-tailed, Wilcoxon matched-pairs signed rank statistical analysis.